Clinical trial
Mono Efficacy of Capecitabine (MoniCa)
NCT00196820 · GBG Forschungs GmbH, Other · Completed
Key facts
| NCT number | NCT00196820 |
|---|---|
| Title | Mono Efficacy of Capecitabine (MoniCa) |
| Official title | A Multicenter Phase II Study to Determine the Efficacy of Capecitabine as First Line Monochemotherapy in Patients With HER2 Negative, Medium-risk, Metastatic Breast Cancer |
| Lead sponsor | GBG Forschungs GmbH, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Capecitabine |
| Enrollment | 200 |
| Start date | Jul 1, 2005 |
| Completion | Dec 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 6, 2011 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: